You also may be interested in...
Congressional Testimony
6/12/2020
S. 2943, SASC. Report for FY 2017, 114-255, Pg. 205
Congressional Testimony
6/9/2020
S. 1124 NDAA Conference Report for FY 1996; Sec. 717, As modified by S. 1356, NDAA Conference Report for FY 2016, Sec. 713
Recommended Content:
About TRICARE
Congressional Testimony
6/5/2020
S. 2474, SAC-D Report for FY 2020,116-103, Pg. 239
Congressional Testimony
5/22/2020
H.R. 2500, HASC Report for FY 2020 116-120 Pg. 159
Congressional Testimony
5/21/2020
H.R. 1625 DoD Approps Act FY 2018 Joint Explanatory Statement, Pg. 998
Congressional Testimony
5/19/2020
H.R. 2745, HAC Report for FY 2020 116-63, Pg. 19
Congressional Testimony
4/27/2020
H.R. 2998, HAC Milcon for FY 2018, 115-188, Pg. 27-28
Congressional Testimony
4/24/2020
S. 1790, SASC Report for FY 2020, 116-48, Pg. 213-214
Recommended Content:
About TRICARE
Congressional Testimony
4/16/2020
S. 1790, NDAA Conference Report for FY 2020, 116-333, Sec. 742
Congressional Testimony
4/13/2020
S. 2943, NDAA Conference and Pharmacies of Military Medical Treatment Facilities Report for FY 2017, Sec. 744(f)
Recommended Content:
Military Health System Transformation
Congressional Testimony
4/13/2020
H.R. 2968, HAC Report for FY 2020, 116-84 Pg. 313-314
Congressional Testimony
4/9/2020
S. 1790, SASC Report for FY 2020, 116-48, Pg. 213
Recommended Content:
About TRICARE
Congressional Testimony
3/13/2020
H.R. 2500, HASC for FY 2020, 116-120, Pg 164-165
Congressional Testimony
3/5/2020
The Honorable Thomas McCaffery Assistant Secretary of Defense (Health Affairs) and Lieutenant General (Dr) Ronald Place Director, Defense Health Agency, Regarding the Military Health System [testified] before the House Appropriations Committee Defense Subcommittee
Showing results 31 - 45
Page 3 of 20